Skip to main content

Latest SEC Filings — Page 81

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Stockholders Approve 4 Million Share Increase for Equity Incentive Plan
Form 8-KFLNA · Form 8-K · 9d ago
Sinovac Biotech Regains Nasdaq Compliance, Averting Delisting
ProForm 6-KSVA · Form 6-K · 9d ago
Director & 10% Owner Buys $128K in Open Market Amidst Financial Concerns
Form 4GDTC · Form 4 · 9d ago
Dr. Reddy's Launches First-to-Market Generic Bosulif® (Bosutinib) in US with 180-Day Exclusivity
ProForm 6-KRDY · Form 6-K · 9d ago
Director & 10% Owner Kosasa Thomas Invests $100K in OneMedNet Amidst Financial Challenges
Form 4ONMD · Form 4 · 9d ago
Birkenstock Announces €900M Senior Notes Offering and New $500M Share Repurchase Authorization
ProForm 6-KBIRK · Form 6-K · 9d ago
SS Innovations Furnishes Updated Investor Presentation Highlighting Growth & Regulatory Milestones
Form 8-KSSII · Form 8-K · 9d ago
Li Auto Repurchases $192.87M in Shares Across May and Early June
ProForm 6-KLI · Form 6-K · 9d ago
ProLogium (TDAC Merger Target) Signs MoU with OPmobility for EV Battery Module Development
ProForm 425TDAC · Form 425 · 9d ago
KE Holdings Cancels $168M in Shares, Continues Buyback Program with $12M in New Repurchases
ProForm 6-KBEKE · Form 6-K · 9d ago
SK Telecom Reports Q1 2026 Financials: Revenue and Profit Decline YoY Amidst AWS Contract and Debt Compliance
Form 6-KSKM · Form 6-K · 9d ago
ING Appoints Hilde Garssen as CHRO to Management Board Banking
Form 6-KING · Form 6-K · 9d ago
Shareholders Approve Amended Articles Formalizing Weighted Voting Rights and Granting New Share Mandates
ProForm 6-KBEKE · Form 6-K · 9d ago
Toyota Finalizes Major Divestiture of Toyota Industries Shares, Records ¥576.9B Consolidated Gain
Form 6-KTM · Form 6-K · 9d ago
Ecopetrol Secures 6-Year Collective Bargaining Agreement with Major Union
Form 6-KEC · Form 6-K · 9d ago
Director-Affiliated Entity Registers $181M Secondary Offering
ProForm S-1PTRN · Form S-1 · 9d ago
Woodside Denies Media Speculation on Exxon Mobil Transaction
Form 6-KWDS · Form 6-K · 9d ago
IperionX Acquires Key Rare Earth & Critical Mineral Assets Adjacent to Titan Project
ProForm 6-KIPX · Form 6-K · 9d ago
Nexentis Finalizes $1.25M Offering at Deep Discount, Adding Significant Dilution
ProForm 424B5NXTS · Form 424B5 · 9d ago
Lotus Technology Secures $128M Convertible Note from Parent Geely Amidst Financial Uncertainty
ProForm 6-KLOT · Form 6-K · 9d ago
ZKH Group Extends $50M Share Repurchase Program for Another Year
Form 6-KZKH · Form 6-K · 9d ago
AITX Targets $175K-$500K Monthly Recurring Revenue from ROAMEO Autonomous Security Deployments
ProForm 8-KAITX · Form 8-K · 9d ago
Alterity Therapeutics Issues 3 Million Options to Executives, Confirming Dilution
ProForm 6-KATHE · Form 6-K · 9d ago
Strive Declares July Preferred Stock Dividends, Confirms Return of Capital Treatment
Form 8-KASST · Form 8-K · 9d ago
Tower Semiconductor Secures Multi-Year InP Epiwafer Supply, Settles IP Dispute with IQE
ProForm 6-KTSEM · Form 6-K · 9d ago
Gilat to Acquire Comtech's Satellite & Space Communications Segment for $157.5M
ProForm 6-KGILT · Form 6-K · 9d ago
Chairman Establishes $72M Collar Transaction for Liquidity, Sells $2.5M in Stock
ProForm 4PCOR · Form 4 · 12d ago
Director & 10% Owner Haveli Investments Continues Accumulation with $5.8M Stock Purchases
ProForm SCHEDULE 13D/ABLND · Form SCHEDULE 13D/A · 12d ago
Belite Bio Completes NDA Submission for Stargardt Disease Drug Tinlarebant
ProForm 6-KBLTE · Form 6-K · 12d ago
SPAC Files Definitive S-4 for Merger with Marine Thinking Inc. Amidst Going Concern Warning and High Dilution
ProForm S-4/AEURK · Form S-4/A · 12d ago